Impact of PNKP mutations associated with microcephaly, seizures and developmental delay on enzyme activity and DNA
John J Reynolds1, Alexandra K Walker, Edward C Gilmore
1Genome Damage and Stability Centre, University of Sussex, Science Park Road, Falmer, Brighton, BN1 9RQ, UK.
Abstract:
Microcephaly with early-onset, intractable seizures and developmental delay (MCSZ) is a hereditary disease caused by mutations in polynucleotide kinase/phosphatase (PNKP), a DNA strand break repair protein with DNA 5'-kinase and DNA 3'-phosphatase activity. To investigate the molecular basis of this disease, we examined the impact of MCSZ mutations on PNKP activity in vitro and in cells. Three of the four mutations currently associated with MCSZ greatly reduce or ablate DNA kinase activity of recombinant PNKP at 30°C (L176F, T424Gfs48X and exon15Δfs4X), but only one of these mutations reduces DNA phosphatase activity under the same conditions (L176F). The fourth mutation (E326K) has little impact on either DNA kinase or DNA phosphatase activity at 30°C, but is less stable than the wild-type enzyme at physiological temperature. Critically, all of the MCSZ mutations identified to date result in ∼ 10-fold reduced cellular levels of PNKP protein, and reduced rates of chromosomal DNA strand break repair. Together, these data suggest that all four known MCSZ mutations reduce the cellular stability and level of PNKP protein, with three mutations likely ablating cellular DNA 5'-kinase activity and all of the mutations greatly reducing cellular DNA 3'-phosphatase activity.
Insights
Microcephaly with early-onset, intractable seizures and developmental delay (MCSZ) is caused by mutations in the DNA repair protein PNKP. These mutations reduce PNKP stability and activity, impairing DNA repair and leading to disease.
Area of Science:
- Genetics
- Molecular Biology
- Biochemistry
Background:
- Microcephaly with early-onset, intractable seizures and developmental delay (MCSZ) is a rare genetic disorder.
- MCSZ is linked to mutations in the polynucleotide kinase/phosphatase (PNKP) gene.
- PNKP is crucial for DNA strand break repair, possessing both kinase and phosphatase activities.
Purpose of the Study:
- To investigate the molecular mechanisms by which MCSZ-associated mutations affect PNKP function.
- To determine the impact of specific MCSZ mutations on PNKP's enzymatic activities and cellular stability.
Main Methods:
- In vitro analysis of recombinant PNKP enzyme activity (kinase and phosphatase assays) at 30°C.
- Assessment of PNKP protein levels and DNA repair rates in cells harboring MCSZ mutations.
- Evaluation of enzyme stability at physiological temperatures.
Main Results:
- Three of four MCSZ mutations significantly reduced or abolished PNKP's DNA kinase activity.
- One mutation (L176F) reduced DNA phosphatase activity, while others had minimal impact at 30°C.
- All mutations led to decreased cellular PNKP levels and impaired chromosomal DNA strand break repair.
- One mutation (E326K) showed reduced stability at physiological temperatures.
Conclusions:
- MCSZ-associated mutations compromise PNKP protein stability and cellular levels.
- Mutations collectively impair both DNA 5'-kinase and 3'-phosphatase activities, leading to reduced DNA repair capacity.
- These molecular defects provide a basis for the pathogenesis of MCSZ.
Related Concept Videos
Nucleotide Excision Repair
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Nucleotide Excision Repair
Long-patch Base Excision Repair
Inborn Errors of Metabolism
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

